Risk factors for drug-related cachexia: an analysis based on the FDA adverse event reporting system (FAERS) from 2004 to 2025
Lingli Huang, Shuchen Dong, Quanli Zhang, Jie Ni · 2026
Read Risk factors for drug-related cachexia: an analysis based on the FDA adverse event reporting system (FAERS) from 2004 to 2025 by Lingli Huang, Shuchen Dong, Quanli Zhang, Jie Ni (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13593894.txt.
Description
Huang and coauthors hunt drugs linked to cachexia in a United States event database. Cachexia is a wasting syndrome that cuts survival and life quality. Systematic proof on drug-induced cachexia has been scarce. The team ran the first large-scale vigilance analysis.
Reports from 2004 to early 2025 were pulled for the study. All reports listed cachexia as an adverse event. The top 50 most reported drugs got deep signal checks. Four methods had to agree for a drug to count as a signal. Risk features were charted for each flagged drug. Results may warn prescribers about wasting risks.
Catalog record
| CREATOR | Lingli Huang, Shuchen Dong, Quanli Zhang, Jie Ni |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |